I am incredibly proud to share that we have received Emergency Use Authorization from @US_FDA for our Omicron BA.4/BA.5-adapted #COVID19 vaccine for people aged 12 and older: on.pfizer.com/3wIpmIX
@AlbertBourla | 58,132 followers
Replying to @AlbertBourla
As Americans prepare for the coming fall and winter seasons, this adapted vaccine will be an important tool, as #COVID19 caused by existing and emerging variants could surge.

Engagement Map

Quotes
Replies
Retweets
Trendsmap

Replies and Quotes

Total of 4 replies and 1 quotes found
In reply to @AlbertBourla
Emergency uses of the Bivalent vaccine have not been approved or licensed by US FDA but have been authorized to prevent COVID-19 in ages 12yrs+. See Fact Sheets: cvdvaccine-us.com
 
In reply to @AlbertBourla
Can you explain to me why jabbed family & friends now have blood clots, heart problems, poor immune systems and are experiencing several bouts of covid while all my unjabbed family & friends are doing just fine?
 
In reply to @AlbertBourla
Unbelievable work you and Pfizer are doing. twitter.com/AAPSonline/sta…
 
 
Over 1 replies and quotes not shown

Retweeters

No retweeters found
4 retweeters not shown
For access to this functionality a Trendsmap Explore subscription is required.

A Trendsmap Explore subscription provides full access to all available timeframes

Find out more

Thanks for trying our Trendsmap Pro demo.

For continued access, and to utliise the full functionality available, you'll need to subscribe to a Trendsmap Pro subscription.

Find out more

This account is already logged in to Trendsmap.
Your subscription allows access for one user. If you require access for more users, you can create additional subscriptions.
Please Contact us if you are interested in discussing discounts for 3+ users for your organisation, or have any other queries.